Nektar Therapeutics · Brief

Next report

11 days

Nov 12 · after closeconfirmedQ3 FY26

Expected move

±3.0%implied · report alone

37.7140.03

straddle ±12.8%

spot 38.87exp Nov 20ATM strike 39ATM straddle 5.88IV 79%

Oct 30 closereport share · term structure

Expected move

—≥ implied

Q2 FY26±5.8%▼−3.82%×0.66

quarterimplied−10%0+10%realized×

Q2 FY26±5.8%▼−3.82%×0.66

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · confirmed

—

NKTR report session

No linked exposure.

Oct 29impliedImplied move: ±12.7% into Nov 12 earnings (Oct 29 close).Source

Oct 27report dateEarnings date confirmed: Nov 12, after close.Source

Oct 22impliedImplied move: ±13.7% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.